EMAIL THIS PAGE TO A FRIEND

Molecular pain

Anxiolytic-like effects of translocator protein (TSPO) ligand ZBD-2 in an animal model of chronic pain.


PMID 25889665

Abstract

The activation of Translocator protein (18xa0kDa) (TSPO) has been demonstrated to mediate rapid anxiolytic efficacy in stress response and stress-related disorders. This protein is involved in the synthesis of endogenous neurosteroids that promote γ-aminobutyric acid (GABA)-mediated neurotransmission in the central neural system. However, little is known about the functions and the underlying mechanisms of TSPO in chronic pain-induced anxiety-like behaviors. The novel TSPO ligand N-benzyl-N-ethyl-2-(7,8-dihydro-7-benzyl-8-oxo-2-phenyl-9H-purin-9-yl) acetamide (ZBD-2) was used in the present study. We found that ZBD-2 (0.15 or 1.5xa0mg/kg) significantly attenuated anxiety-like behaviors in mice with chronic inflammatory pain induced by hindpaw injection of complete Freund's adjuvant (CFA). However, the treatment did not alter the nociceptive threshold or inflammation in the hindpaw. Hindpaw injection of CFA induced the upregulation of TSPO, GluR1-containing α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, and NR2B-containing N-methyl-D-aspartate (NMDA) receptors in the basolateral amygdala (BLA). ZBD-2 administration reversed the alterations of the abovementioned proteins in the BLA of the CFA-injected mice. Electrophysiological recording revealed that ZBD-2 could prevent an imbalance between excitatory and inhibitory transmissions in the BLA synapses of CFA-injected mice. Therefore, as the novel ligand of TSPO, ZBD-2 induced anxiolytic effects, but did not affect the nociceptive threshold of mice under chronic pain. The anxiolytic effects of ZBD-2 were related to the regulation of the balance between excitatory and inhibitory transmissions in the BLA.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1405553
Anti-CAMK2A antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB4501293
Anti-GLUR1, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4501294
Anti-GLUR1, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4300507
Anti-GRIA1 (Ab-849) antibody produced in rabbit, affinity isolated antibody
SAB4300508
Anti-GRIA1 (Ab-863) antibody produced in rabbit, affinity isolated antibody
HPA035202
Anti-GRIA1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2106412
Anti-GRIA1 antibody produced in rabbit, affinity isolated antibody
SAB2100974
Anti-GRIN2A antibody produced in rabbit, affinity isolated antibody
SAB4501304
Anti-NMDAR2A, C-Terminal antibody produced in rabbit, affinity isolated antibody
WH0000815M1
Monoclonal Anti-CAMK2A antibody produced in mouse, clone 2C4, purified immunoglobulin, buffered aqueous solution
SAB1403629
Monoclonal Anti-CAMK2A antibody produced in mouse, clone 2C12, purified immunoglobulin, buffered aqueous solution
WH0002571M2
Monoclonal Anti-GAD1 antibody produced in mouse, clone 5E11, purified immunoglobulin, buffered aqueous solution
SAB1403849
Monoclonal Anti-GAD1 antibody produced in mouse, clone 1D12, ascites fluid
SAB1402214
Monoclonal Anti-GRIN2B antibody produced in mouse, clone 2G5, purified immunoglobulin, buffered aqueous solution